EWM
Essex Woodlands Management Portfolio holdings
AUM $279M
1-Year Return
29.39%
This Quarter Return
+48.69%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$504M
AUM Growth
+$184M
(+57%)
Cap. Flow
+$42.6M
Cap. Flow
% of AUM
8.45%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
1
Increased
–
Reduced
1
Closed
4
Top Buys
| 1 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
+$83.5M |
Top Sells
| 1 |
ELGX
Endologix Inc
ELGX
|
+$26.8M |
| 2 |
Alaunos Therapeutics
TCRT
|
+$13.7M |
| 3 |
Curis
CRIS
|
+$350K |
| 4 |
PTN
Palatin Technologies
PTN
|
+$17K |
| 5 |
ECTE
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
|
+$17K |
Sector Composition
| 1 | Healthcare | 94.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1
DELISTED
Abiomed Inc
ABMD
| $225M | 44.73% |
3,150,000
| – | – |
|
|
RVNC
2
DELISTED
Revance Therapeutics, Inc.
RVNC
| $95.2M | 18.88% |
4,592,047
| – | – |
|
|
ENTL
3
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $83.5M | 16.57% |
+3,813,196
| New | +$83.5M |
|
|
CORI
4
DELISTED
Corium International, Inc.
CORI
| $61.3M | 12.15% |
9,353,304
| – | – |
|
|
ELGX
5
DELISTED
Endologix Inc
ELGX
| $26.8M | 5.32% |
125,747
-125,747
| -50% | -$26.8M |
|
|
ACUR
6
DELISTED
Acura Pharmaceuticals Inc
ACUR
| $7.73M | 1.53% |
2,056,977
| – | – |
|
7
MediciNova
MNOV
$60.8M
| $4.1M | 0.81% |
1,170,370
| – | – |
|
|
8
Curis
CRIS
$21.6M
| – | – |
-2,338
| Closed | -$350K |
|
|
PTN
9
DELISTED
Palatin Technologies
PTN
| – | – |
-957
| Closed | -$17K |
|
|
10
Alaunos Therapeutics
TCRT
$5.25M
| – | – |
-18,003
| Closed | -$13.7M |
|
|
ECTE
11
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
| – | – |
-12,319
| Closed | -$17K |
|